GSK shares sink after FDA panel rejects Blenrep cancer drug, raising doubts over turnaround strategy. GSK (LSE: GSK) investors took a sharp knock on Friday after its much-hyped blood cancer drug, ...

The Burberry turnaround is very much in its opening chapters, but the worst of the sales collapse may be in the rear-view mirror. The next big test will be whether fresh collections can tempt shoppers ...